Please Wait.....
Report
Cell and Gene Therapy Tools, and Reagents: Global Markets
Market Research Report I 2024-11-07 I 136 Pages I BCC Research
Description
Report Scope
This report analyzes the global market for cell and gene therapy tools and reagents. The market is segmented by product type, disease or application, end user and region. Product types include gene vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome monitoring, cryopreservation reagents, and solutions and media. Diseases or applications include cancer and rare diseases. End users include pharmaceutical and biotech companies, academic research institutes, and clinical laboratories. The regions covered are North America, Europe, Asia-Pacific and the Rest of the World (RoW). For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
This report also examines strategies and collaborations, discusses the regulatory landscape, and analyzes macroeconomic factors when considering new technologies, the industry's increasing competitiveness, and emerging customer needs. This report also examines analytical frameworks, such as ESG analysis, patent analysis, competitive analysis, and strategic recommendations, which will aid companies in devising their strategic plans.
Report Includes
- 44 data tables and 57 additional tables
- An update on the global market for cell and gene therapy tools and reagents
- Analyses of the global market trends, with historic market revenue for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- A look at the market potential for the cell and gene therapy tools and reagents in the life sciences industry, market drivers, and forecasts for the market segments of product, application, end user and region
- Facts and figures pertaining to major market dynamics, product innovations, clinical trials, and government regulations
- Review of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
- Coverage of the technological, economic and business considerations of the market, and the vendor landscape
- Analysis of the industry's regulatory framework and policies, and product pipeline
- Discussion of ESG challenges and ESG practices in the industry
- Market share analysis of the key companies in the industry and coverage of their proprietary technologies and strategies
- Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Sartorius CellGenix GmbH, and Miltenyi Biotec
Executive Summary
Summary:
Cell and gene therapy (CGT) is emerging as an essential tool for safeguarding human health. Techniques such as chimeric antigen receptor T-cell (CAR-T) therapy have emerged as ways to treat many cancers. dThe promise of gene therapy using technologies such as clustered regularly interspaced short palindromic repeats (CRISPR) is being realized in clinical trials. Therapies are being scaled up to treat lifethreatening The global CDMO market was valued at $128 billion in 2023. The market is expected to grow at a compound annual growth rate (CAGR) of 7.0% to reach approximately $191.6 billion by the end of 2029.
The CDMO sector is dynamic and offers service providers a wealth of opportunities for expansion. As the CDMO sector is trending toward consolidation, CDMO businesses are shifting focus to become one-stop shops or integrated pharmaceutical service providers.
With comprehensive services covering the whole drug development and manufacturing process, CDMOs
are essential to the pharmaceutical industry. What distinguishes CDMOs from other service providers is
this end-to-end support. A CDMO can offer services like pre-formulation and formulation development
in the early phases of drug development. After the drug formulation is created, the CDMO can help with
stability testing as well. A CDMO can supply clinical trial materials once the drug enters the clinical trial
stage. These materials consist of the investigational medicinal product (IMP) that will be given to
patients throughout the study and the paperwork required to comply with regulatory requirements.
Ultimately, a CDMO can increase production from clinical trial quantities to commercial-scale quantities
after the drug is approved for marketing. They can also manage the final product's packaging and
delivery.
- Thermo Fisher Scientific Inc.
diseases such as cancer and rare gene-based diseases. As these therapies come to the fore,
a new market for tools to develop these therapies using standard methodologies is emerging. CGT uses
cells and genetic material to fight diseases. Cell therapy involves the transplantation of healthy human
cells into a patient's body to replace or repair diseased or damaged tissue or cells. Gene therapy
modifies a patient's genetic material. These are overlapping fields. Some products are developed using
both cell and gene therapies. Tools and reagents are required to develop cell and gene therapies.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Technology Background: Cell Therapy
Types of Cell Therapy
Technology Background: Gene Therapy
Types of Gene Therapy
Approved CGT Products
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Investments in CGT Research
Capacity Expansions for Clinical and Commercial Manufacturing
Increasing Incidence of Chronic Diseases
Collaborations and Acquisitions
Market Restraints
Complexity in Manufacturing and Supply Chain
Lack of Skilled Force
Market Opportunities
Harnessing the Advances in CGT Technologies
Regulatory Landscape
Gene Therapy Regulations
Cell Therapy Regulations
Viral and Non-Viral Vectors
Media
GMP Proteins and Antibodies
Leukapheresis
CGT Regulations in Europe
Chapter 4 Emerging Technologies and Developments
Closed and Automated Systems
Single-Use Technologies
Chapter 5 Market Segmentation Analysis
Market Trends
Segmentation Breakdown
Global Market for CGT Tools and Reagents, by Product
Immunoassays
Bioreactors
Leukapheresis
GMP Antibodies
Multiplex Immunoassays
Vectors
Cell Separation
Cryopreservation
Cell Expansion
Media
GMP Proteins
GMP Small Molecules
CRS Monitoring
Global Market for CGT Tools and Reagents, by Application
Cancer
Rare Diseases
Other Diseases
Global Market for CGT Tools and Reagents, by End User
Pharmaceutical and Biotech Companies
Academic and Research Institutes
Clinical Laboratories
Geographic Breakdown
Global Market for CGT Tools and Reagents, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Ranking of Leading Players
Strategies of Leading Companies
Product Launches
Collaborations and Partnerships
Expansions
Agreements
Acquisitions
Others
Chapter 7 Sustainability in the CGT Tool and Reagent Market: ESG Perspective
Introduction to ESG
ESG Performance in the Industry
ESG Practices in the CGT Tool and Reagent Industry
Environmental Performance
Concluding Remarks from BCC Research
Chapter 8 Appendix
Methodology
Abbreviations
References
Company Profiles
ABCAM LTD.
ADVERUM BIOTECHNOLOGIES INC.
AKRON BIOTECH
BIO-RAD LABORATORIES INC.
BIO-TECHNE
CYTIVA
FUJIFILM IRVINE SCIENTIFIC
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
QIAGEN
REVVITY
SARTORIUS CELLGENIX GMBH
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A : Global Market for CGT Tools and Reagents, by Application, Through 2029
Summary Table B : Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 1 : Approved CGT Products, as of 2024
Table 2 : Global Cancer Statistics, 2022
Table 3 : Global Market for CGT Tools and Reagents, by Product, Through 2029
Table 4 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
Table 5 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
Table 6 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
Table 7 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
Table 8 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
Table 9 : Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
Table 10 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
Table 11 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
Table 12 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
Table 13 : Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
Table 14 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
Table 15 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
Table 16 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
Table 17 : Global Market for CGT Tools and Reagents, by Application, Through 2029
Table 18 : Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
Table 19 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
Table 20 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
Table 21 : Global Market for CGT Tools and Reagents, by End User, Through 2029
Table 22 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
Table 23 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
Table 24 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
Table 25 : Global Market for CGT Tools and Reagents, by Region, Through 2029
Table 26 : North American Market for CGT Tools and Reagents, by Product, Through 2029
Table 27 : North American Market for CGT Tools and Reagents, by Application, Through 2029
Table 28 : North American Market for CGT Tools and Reagents, by End User, Through 2029
Table 29 : European Research Initiatives Focused on Personalized Medicine
Table 30 : European Market for CGT Tools and Reagents, by Product, Through 2029
Table 31 : European Market for CGT Tools and Reagents, by Application, Through 2029
Table 32 : European Market for CGT Tools and Reagents, by End User, Through 2029
Table 33 : Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
Table 34 : Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
Table 35 : Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
Table 36 : RoW Market for CGT Tools and Reagents, by Product, Through 2029
Table 37 : RoW Market for CGT Tools and Reagents, by Application, Through 2029
Table 38 : RoW Market for CGT Tools and Reagents, by End User, Through 2029
Table 39 : Leading Companies in the CGT Tool and Reagent Market, 2023
Table 40 : Product Launches in the Market for CGT Tools and Reagents, 2021-2024
Table 41 : Collaborations and Partnerships in the CGT Tool and Reagent Market, 2022-2024
Table 42 : Expansions in the Market for CGT Tools and Reagents, 2022-2024
Table 43 : Agreements in the Market for CGT Tools and Reagents, 2022-2024
Table 44 : Acquisitions in the CGT Market for Tools and Reagents, 2022-2024
Table 45 : Other Developments in the Market for CGT Tools and Reagents, 2023 and 2024
Table 46 : Focus Areas in ESG Metrics
Table 47 : Environmental Performance Initiatives in the CGT Tool and Reagent Market
Table 48 : Social Performance Initiatives in the CGT Tool and Reagent Market
Table 49 : Governance Performance Initiatives in the CGT Tool and Reagent Market
Table 50 : ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
Table 51 : Abbreviations Used in this Report
Table 52 : Abcam Ltd.: Company Snapshot
Table 53 : Abcam Ltd.: Financial Performance, FY 2022 and 2023
Table 54 : Abcam Ltd.: Product Portfolio
Table 55 : Abcam Ltd.: News/Key Developments, 2022 and 2023
Table 56 : Adverum Biotechnologies Inc.: Company Snapshot
Table 57 : Adverum Biotechnologies Inc.: Financial Performance, FY 2022 and 2023
Table 58 : Adverum Biotechnologies Inc.: Product Portfolio
Table 59 : Adverum Biotechnologies Inc.: News/Key Developments, 2022-2024
Table 60 : Akron Biotech: Company Snapshot
Table 61 : Akron Biotech: Product Portfolio
Table 62 : Akron Biotech: News/Key Developments, 2022-2024
Table 63 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 64 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
Table 65 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 66 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021-2024
Table 67 : Bio-Techne: Company Snapshot
Table 68 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 69 : Bio-Techne: Product Portfolio
Table 70 : Bio-Techne: News/Key Developments, 2023 and 2024
Table 71 : Cytiva: Company Snapshot
Table 72 : Cytiva: Product Portfolio
Table 73 : Cytiva: News/Key Developments, 2023 and 2024
Table 74 : FUJIFILM Irvine Scientific: Company Snapshot
Table 75 : FUJIFILM Irvine Scientific: Product Portfolio
Table 76 : FUJIFILM Irvine Scientific: News/Key Developments, 2022 and 2023
Table 77 : Miltenyi Biotec: Company Snapshot
Table 78 : Miltenyi Biotec: Product Portfolio
Table 79 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 80 : Proteintech Group Inc.: Company Snapshot
Table 81 : Proteintech Group Inc.: Product Portfolio
Table 82 : QIAGEN: Company Snapshot
Table 83 : QIAGEN: Financial Performance, FY 2022 and 2023
Table 84 : QIAGEN: Product Portfolio
Table 85 : QIAGEN: News/Key Developments, 2022-2024
Table 86 : Revvity: Company Snapshot
Table 87 : Revvity: Financial Performance, FY 2022 and 2023
Table 88 : Revvity: Product/Solutions Portfolio
Table 89 : Revvity: News/Key Developments, 2023 and 2024
Table 90 : Sartorius CellGenix GmbH: Company Snapshot
Table 91 : Sartorius CellGenix GmbH: Product Portfolio
Table 92 : Sartorius CellGenix GmbH: News/Key Developments, 2023 and 2024
Table 93 : STEMCELL Technologies: Company Snapshot
Table 94 : STEMCELL Technologies: Product Portfolio
Table 95 : STEMCELL Technologies: News/Key Developments, 2022-2024
Table 96 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 97 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 98 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 99 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 and 2023
List of Figures
Summary Figure A : Global Market for CGT Tools and Reagents, by Application, 2021-2029
Summary Figure B : Global Market for CGT Tools and Reagents, by Region, 2021-2029
Figure 1 : Market Dynamics of CGT Tools and Reagents
Figure 2 : CGT Sector Investments, 2018-2023
Figure 3 : CGT Sector Investments, by Deal Type, Q1 2024
Figure 4 : Global Market Shares of CGT Tools and Reagents, by Product, 2024
Figure 5 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
Figure 6 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
Figure 7 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
Figure 8 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
Figure 9 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
Figure 10 : Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
Figure 11 : Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
Figure 12 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
Figure 13 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
Figure 14 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
Figure 15 : Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
Figure 16 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
Figure 17 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
Figure 18 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
Figure 19 : Global Market Shares of CGT Tools and Reagents, by Application, 2024
Figure 20 : Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
Figure 21 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
Figure 22 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
Figure 23 : Global Market Shares of CGT Tools and Reagents, by End User, 2024
Figure 24 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
Figure 25 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
Figure 26 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
Figure 27 : Global Market Shares of CGT Tools and Reagents, by Region, 2024
Figure 28 : North American Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 29 : North American Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 30 : North American Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 31 : European Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 32 : European Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 33 : European Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 34 : Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 35 : Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 36 : Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 37 : RoW Market for CGT Tools and Reagents, by Product, 2021-2029
Figure 38 : RoW Market for CGT Tools and Reagents, by Application, 2021-2029
Figure 39 : RoW Market for CGT Tools and Reagents, by End User, 2021-2029
Figure 40 : How a Strong ESG Proposition Benefits Businesses
Figure 41 : Abcam Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 42 : Abcam Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 43 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2023
Figure 44 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2023
Figure 45 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 46 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 47 : QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 48 : QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 49 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 50 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 51 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 52 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security